TABLE 13

Ontogeny profile of hepatic CYP enzymes in domestic pig based on metabolic activity, protein expression, and mRNA expression levels

Percentages represent expression/activity relative to adult levels.

Onset of Activity and/or ExpressionAdult Levels ReachedAge-Related Changes in Activity/ExpressionCommentsReferences
CYP1A2
 Protein expressionM: 2 days (5.4%); F: 2 days (2.2%)NR (180 days)M: increased rapidly; F: increased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2A19
 Protein expressionM: 2 days (11%); F: 2 days (2.3%)NR (180 days)Increased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2B22
 Protein expressionM: 2 days (8.6%); F: 2 days (10%)180 daysIncreased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2C
 Catalytic activityM: 2 days (14%); F: 2 days (45%)M: NR; F: 56 daysM: increased progressively; F: increased rapidlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Substrate: Tolbutamide 4-hydroxylation. Methods: PLM. Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2C33
 Protein expressionM: 2 days (8.6%); F: 2 days (10%)180 daysIncreased progressivelySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2C34
 Protein expressionM: 2 days (38%); F: 2 days (30%)M: NR (210% at 28 days); F: NR (165% at 28 days)Increased rapidlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2C35
 Protein expressionM: 2 days (30%); F: 2 days (24%)M: NR (155% at 28 days); F: NR (129% at 28 days)Increased rapidly/inconsistent patternSingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2C36
 Protein expressionM: 2 days (9%); F: 2 days (58%)M: NR (180 days); F: 28 daysM: increased slowly; F: increased rapidlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2C49
 Protein expressionM: 2 days (12%); F: 2 days (10%)28 daysIncreased rapidlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2D6
 Protein expressionM: 2 days (6%); F: 2 days (5%)NR (180 days)Increased rapidly/increased progressivelySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2E
 Catalytic activityM: 2 days (49%); F: 2 days (78%)NR (180 days)Increased slowly/no changesSingle study, sparse data. Adult age: 180 days. Fetal development: NR. Substrate: Chlorzoxazone 6-hydroxylation. Methods: PLM. Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP2E1
 Protein expressionM: 2 days (108%); F: 2 days (31%)M: 2 days; F: NR (180 days)M: no changes; F: increased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP3A
 Catalytic activityM: 2 days (13%); F: 2 days (8%)NR (180 days)Increased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Substrate: Midazolam 1-hydroxylation. Methods: PLM. Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP3A22
 Protein expressionM: 2 days (35%); F: 2 days (20%)NR (180 days)Increased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP3A46
 Protein expressionM: 2 days (2.3%); F: 2 days (2.9%)NR (180 days)Increased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP4A21
 Protein expressionM: 2 days (16%); F: 2 days (17%)NR (180 days)Increased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F). Matrix: PLMMillecam et al. (2018)
CYP4A24
 Protein expressionM: 2 days (44%); F: 2 days (60%)NR (180 days)Increased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP20A1
 Protein expressionM: 2 days (60%); F: 2 days (45%)NR (180 days)Increased slowly/no changesSingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
CYP51A1
 Protein expressionM: 2 days (26%); F: 2 days (17%)1 NR (180 days)Increased slowlySingle study, sparse data. Adult age: 180 days. Fetal development: NR. Methods: LC-MS/MS (PLM). Strain: Seghers hybrid (M/F)Millecam et al. (2018)
  • F, female; M, male; NR, not reported; PLM, pig liver microsome.